Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 1/20 | 0.53 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CTSD | P07339 | 1/20 | 0.49 |
| ▸ | HCN1 | O60741 | 1/20 | 0.47 |
| ▸ | HCN4 | Q9Y3Q4 | 1/20 | 0.47 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.45 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5161043 | 1.00 | KCNA3 (0.62) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5162069 | 0.88 | KCNA3 (0.65) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL7976348 | 0.88 | KCNA3 (0.65) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5159523 | 0.85 | KCNA3 (0.68) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5159459 | 0.85 | KCNA3 (0.68) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5157294 | 0.84 | KCNA3 (0.75) | KCNA3HPGDTP53GLAALDH1A1 | |
| SCHEMBL4965050 | 0.82 | KCNA3 (0.69) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5160776 | 0.81 | KCNA3 (0.62) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5161979 | 0.81 | KCNA3 (0.62) | KCNA3HPGDTP53GLAGAA | |
| SCHEMBL5158992 | 0.79 | KCNA3 (0.76) | KCNA3HPGDTP53GLAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368020-B1 | METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS | MERCK & CO INC (US) | 2008-03-05 | — | — | EP | claimed |
| EP-1126836-B1 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | MERCK & CO INC (US) | 2007-02-14 | — | — | EP | claimed |
| US-20040115739-A1 | Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells | GARCIA MARIA L (US) | 2004-06-17 | — | — | US | claimed |
| WO-2002060340-A9 | METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS | MERCK & CO INC (US) | 2002-11-21 | — | — | WO | claimed |
| US-6194458-B1 | 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS | MERCK & CO., INC. | 2001-02-27 | — | — | US | claimed |
| EP-1368020-B1 | METHOD FOR IDENTIFYING MAXI-K CHANNEL BLOCKERS | MERCK & CO INC (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1126836-B1 | BENZAMIDE POTASSIUM CHANNEL INHIBITORS | MERCK & CO INC (US) | 2007-02-14 | — | — | EP | disclosed |
| US-20040115739-A1 | Method for identifying maxi-k channel blockers for use in lowering elevated intraocular pressure using hek-293 cells | GARCIA MARIA L (US) | 2004-06-17 | — | — | US | disclosed |
| US-6194458-B1 | 1-(2-METHOXYPHENYL)-1-OXO-2-AZA-(S)-4-I-BUTYL-4-PHENYLBUTANE, FOR EXAMPLE; TREATING VARIOUS CONDITIONS INCLUDING TRANSPLANTATION REJECTION OF ORGANS OR TISSUES IN A PATIENT; IMMUNOSUPPRESSANT COMPOSITIONS | MERCK & CO., INC. | 2001-02-27 | — | — | US | disclosed |